Here are patient safety issues that have appeared in the news and medical journals throughout the last 30 days or so:
Toni
Clarke, for Reuters, reported that AstraZeneca's diabetes drug, Onglyza,
may be associated with an increased risk of death due to heart failure.
A
study published in Circulation demonstrated that sudden cardiac arrest
during sports activity occur most frequently in middle age, but the outcomes
following such events are usually better. This is because the events are
usually witnessed by others and followed by cardiopulmonary resuscitation.
Research
undertaken by the American Orthopaedic Society for Sports Medicine demonstrated
that one in three children who undergo ACL surgery experience a re-injury to
the same ligament.
An
article published in Annals of Internal Medicine discussed the 2015
American Diabetes Associations’ Standards of Medical Care in Diabetes which recommended
lowering the floor body mass index of Asian-Americans which should prompt
investigation into diabetes from 25 to 23, tailoring plans for blood glucose
control to individual patients by considering age, other co-morbid medical
conditions, life expectancy and the patient’s motivation and preferences.
Finally, statins are now recommended for all diabetes patients older than 40.
